Tech Company Financing Transactions
EVS Glaucoma Therapeutics Funding Round
On 9/12/2013, EVS Glaucoma Therapeutics received investment from CIT GAP Fund.
Transaction Overview
Company Name
Announced On
9/12/2013
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to pursue further development of its delivery system.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2776 Towerview Rd.
Herndon, VA 20171
USA
Herndon, VA 20171
USA
Phone
Undisclosed
Email Address
Not Recorded
Overview
EVS Glaucoma Therapeutics, a Herndon-based spinout of Euclid Vision Systems that develops a sustained delivery system for glaucoma medication. EGT develops an implantable, bio-degradable, collagen-based drug delivery system for Latanoprost, the leading prescribed glaucoma medication.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Ross
Browse more venture capital transactions:
Prev: 9/12/2013: Intra-Cellular Therapies venture capital transaction
Next: 9/12/2013: Okta venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs